BioVeris Products Used for Security at Olympic Games

World's Athletes In Athens Protected Using BioVeris Technology

02-Sep-2004 - BioVeris Corporation announced that the NATO Response Forces (NRF) in charge of the security operations for the Olympic Games in Athens, Greece purchased BioVeris' detection products to screen for biological agents in potential security alerts during the Games. BioVeris' biological detection ...

Scottish Life Sciences Sector set to Benefit from South Korean Institute Opening in Glasgow

02-Sep-2004 - The Korea Health Industry Development Institute (KHIDI) has announced today (Wed Sept 1st 2004) the establishment of an office at the West of Scotland Science Park in Glasgow to help manage a multi-million investment in Scottish drug development research projects. KHIDI, on behalf of the South ...

Chiron Acquires Prion Solutions Inc.

Agreement Enhances Company's Commitment to Safeguard the Blood Supply

01-Sep-2004 - Chiron Corporation announced that it had acquired Prion Solutions Inc., a privately held company based in La Jolla, Calif., focused on research into variant Creutzfeldt-Jakob disease (vCJD) and other prion-related diseases. Financial terms of the acquisition were not disclosed. "At Chiron we ...

SEQUENOM Signs Research Agreement with Translational Genomics Research Institute

Collaboration Aims to Provide a Comprehensive Portfolio of Genetic Markers for Melanoma Predisposition and Prognosis

01-Sep-2004 - SEQUENOM, Inc. announced a research agreement with the Translational Genomics Research Institute (TGen) where SEQUENOM will provide TGen access to its candidate gene portfolio of targets associated with an individual's predisposition for skin cancer. TGen will further validate these candidate ...

NIGMS Funds Center for Quantitative Biology

Broad Collaboration, Advanced Computing Join in Study of Biocomplexity

01-Sep-2004 - To probe the complexities of living systems, the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH), has established its fifth Center of Excellence in Complex Biomedical Systems Research. The new center, headed by David Botstein, Ph.D., at ...

Patented process preserves transplant tissues/organs

31-Aug-2004 - Body tissues such as blood vessels, cartilage and skin?even whole organs such as kidneys, livers and hearts?could become more widely available for transplants as a result of a patent issued recently to Organ Recovery Systems of Chicago for a method to chill body tissues and organs well below ...

Merz Pharmaceuticals and NascaCell Announce Collaboration Agreement to use Aptamers in the Validation of several Targets

31-Aug-2004 - Frankfurt and Munich. Merz Pharmaceuticals and NascaCell announced that they have entered into a collaboration agreement. The focus is on the use of aptamers for the enhanced validation of different targets for products in research and development at Merz Pharmaceuticals. "We are delighted to ...

eGene Announces Financial Advisory Agreement with MBC Global

31-Aug-2004 - eGene Inc. has signed a one-year financial advisory agreement with MBC Global, LLC, an international merchant banking company located in Lake Forest, Ill. MBC Global facilitated the merger between Centroid Consolidated Mines Co. , which was a public company, and BioCal Technology Inc. ...

Navigant Biotechnologies awarded additional USD 2 M Department of Defense research funding

30-Aug-2004 - Gambro's wholly owned subsidiary, Navigant Biotechnologies, Inc., announces that the U.S. Department of Defense (DOD) has awarded it an additional USD 2 million grant to continue to develop and test its Mirasol(TM) Pathogen Reduction Technology (PRT) for applications improving the safety and ...

IC-MedTech Licenses Promising Cancer Therapeutic From Summa Health System

Dual Small Molecule Approach Demonstrates Ability to Induce a Wide Range of Cancer Cells to Self-Destruct in Animal Models

30-Aug-2004 - Indian Creek Medical Technologies, LLC announced it has exclusively licensed a novel anti-cancer therapeutic that, in animal studies, causes a wide variety of cancer cells to self destruct. Developed by Summa scientists, together with research teams from several universities and hospitals in the ...